MD+DI writes about the Levita Magnetics® Series C funding announcement. The $26 million round will be used to support the regulatory and near-term commercial efforts for the Magnetic-Assisted Robotic Surgery (MARS™) platform. Levita also announced the appointment of...
Series C financing to support regulatory process and initial market entry of the Levita® MARSTM platform designed to make robotic surgery accessible for all Menlo Park, California—August 11, 2022—Business Wire—Levita Magnetics, on a mission to provide patients with...
In this episode of the DeviceTalks Weekly Podcast, Levita Magnetics Founder and CEO Alberto Rodriguez-Navarro, M.D. speaks with host Tom Salemi about Levita’s past, present, and future. Hear the origin story of how Alberto developed the Magnetic Surgery System as a...
Menlo Park, California – July 6, 2021 – Business Wire – Levita Magnetics, a company with a mission to improve access to better surgery for more patients, today announced that the first ever robotic-assisted surgical procedures have been performed...
San Mateo, California – January 31, 2019 – Levita Magnetics®, a company dedicated to improving the outcomes of surgical procedures through Magnetic Surgery®, today announced publication of clinical data in Obesity Surgery, the official journal of the International...
